An Extended Use Study of Safety and Efficacy of OncoVEXGM-CSF in Melanoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
BioVex Limited
ClinicalTrials.gov Identifier:
NCT01368276
First received: April 20, 2011
Last updated: March 6, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)